Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
Abstract Background Deficiency of interleukin-36 receptor antagonist (DITRA) is a life threatening monogenic autoinflammatory disease caused by loss of function mutations in the IL36RN gene. Affected patients develop recurrent episodes of generalized pustular psoriasis (GPP) with systemic inflammati...
Saved in:
Main Authors: | Toni Hospach (Author), Fabian Glowatzki (Author), Friederike Blankenburg (Author), Dennis Conzelmann (Author), Christian Stirnkorb (Author), Chris Sandra Müllerschön (Author), Peter von den Driesch (Author), Lisa Maria Köhler (Author), Meino Rohlfs (Author), Christoph Klein (Author), Fabian Hauck (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Woronoff Ring in Deficiency of Interleukin-36 Receptor Antagonist (DITRA)
by: Daniel Morgado-Carasco, et al.
Published: (2019) -
Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series
by: Chang-Yu Hsieh, et al.
Published: (2024) -
Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin
by: Edwin Cuperus, MD, et al.
Published: (2018) -
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
by: Francisco Gómez-García, et al.
Published: (2018) -
A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
by: Chiharu Tominaga, et al.
Published: (2015)